Learn article
What the STRYDE nail was, why it was withdrawn from the market, what corrosion and osteolysis findings led to the recall, and the current state of weight-bearing internal lengthening nail development.
STRYDE is not a current U.S. implant option: the FDA states that stainless-steel Precice devices, including STRYDE, remain recalled and should not be implanted. PRECICE MAX is also not appropriately described as a routine full-weight-bearing successor while its Class II recall remains open. [1][2]
STRYDE was a stainless-steel magnetically driven lengthening nail designed to tolerate higher loading than earlier titanium PRECICE configurations. Greater permitted loading could change transfers, walking practice, and daily independence. Those intended advantages must be considered alongside the later biocompatibility concerns and recall.
A matched-pair analysis reported osteolysis in 31 of 48 STRYDE segments versus 1 of 91 PRECICE segments. The study also reported implant failure and pain findings, while observing that osteolysis generally resolved after implant removal. Observational results do not establish that every recipient will have the same outcome. [3]
The FDA's June 2023 update says stainless-steel Precice Bone Transport, Plate, and STRYDE devices remain recalled from the U.S. market due to adverse events related to potential biocompatibility concerns and should not be implanted. The same update distinguishes the titanium PRECICE IMLL system and reminds clinicians to follow its current instructions, including removal after one year. [1]
PRECICE MAX received 510(k) clearance in December 2023. The manufacturer initiated a recall on September 30, 2024 over potential design, manufacturing, and validation-documentation issues. The FDA classified it as Class II, and the record remained open on July 12, 2026. The recall action told customers to cease use of unimplanted affected devices and return them. [2]
A product described as stronger or designed for higher loading is not automatically available, unrecalled, appropriate for a particular patient, or permitted for full loading in every phase.
Current U.S. indications, weight and implant-count limits, one-year removal instruction, and stainless-steel device recall status.
Recall initiated September 30, 2024. The FDA record was open when reviewed on July 12, 2026.
Informational only. Not medical advice.